Study Group: Pharmaceutical Regulation and FDA Experts: Lawyers(?)
Council Members in this Study Group: 49
Request a survey with this Study Group
Leading Experts in this Study Group
 |
What is a GLG Leader? |
Stephen BentPartner & Co-Chair, Life Sciences
Foley & Lardner LLP
Stephen A. Bent is Partner and co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated with biotechnology...
Volunteer Professor of Law
University of Cincinnati - CC
James O'Reilly is a Volunteer Professor of Law at University of Cincinnati, where he has counseled large and small drug, biotech, device and food firms since becoming a full time professor in 1998. Prof. O’Reilly’s 31 books and 137 articles have been widely cited, and as an FDA expert over many years...
Thomas SaundersPartner
Seyfarth Shaw LLP
Thomas Saunders is a Partner at Seyfarth Shaw in Boston, Massachusetts, where he specializes in representing emerging medical technology, biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, patent strategy, IP licensing matters and ANDA Paragraph IV...
Marc ScheinesonPartner & Chair, Food and Drug Practice
Alston & Bird LLP
Marc Scheineson is a Partner with Alston & Bird where he heads the firm's Food and Drug Law Practice. He has practiced food and drug law, health care law and administrative law for over 20 years in national law firms and at the FDA. His practice focuses on determining the regulatory course of least...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Experts(?)
Product liability exposure of new materials makers can be severe, especially with fatal consequences of failures Internal memos re product problems can shoot company in the foot; prudent firms have a plan for controlling open-ended speculative memos in an instant-message environment Major PR and govt....
Recent reports by a federal study panel, addressed in stories in the NY Times and other sources, highlight one more gap between expectations and reality in the resource-starved federal safety net for consumers. Much less is being done to oversee Gene Test kits than consumers may expect; eventually there...
Product shelf-life is a major economic concern for the agricultural industry. The biological mechanism for regulating the ripening of fruits is mediated by ethylene. Ethylene management is addressed in three ways: 1) Ethylene...
"Son of Asbestos" claims may sound extreme; but the lead paint makers would be prudent to collectively negotiate and fund a 50-state settlement that follow the tobacco companies' model and avoids the bankruptcy model of the asbestos-using firms. Lead injury awareness has increased and demands for public...
-Name Brands vs, Knock-Offs: Strategies and Counter-Strategies -Vulnerabilities of Name Brand Copyrights -Why the internet Knock-Off market will always exist
Most Common Company Types:
- Law Firm (general practice/large)
- Law Firm (Boutique / Specialized)
- Pharmaceuticals Manufacturer
Most Common Job Types:
- Partner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms